Alfacalcidol | List of Frontiers open access articles

Original Research

Published on 01 Feb 2024

Effects of active vitamin D analogues on muscle strength and falls in elderly people: an updated meta-analysis

in Endocrinology of Aging

An Xiong
Haibo Li
Miaoying Lin
Feng Xu
Xuedi Xia
Dexing Dai
Ruoman Sun
Yali Ling
Lei Qiu
Rui Wang

Frontiers in Endocrinology

doi 10.3389/fendo.2024.1327623

7,552 views
13 citations

Original Research

Published on 12 Aug 2021

Association Between Secondary Hyperparathyroidism and Body Composition in Pediatric Patients With Moderate and Advanced Chronic Kidney Disease

in Pediatric Nephrology

Vasiliki Karava
Antonia Kondou
John Dotis
Athanasios Christoforidis
Anna Taparkou
Konstantina Tsioni
Evangelia Farmaki
Konstantinos Kollios
Ekaterini Siomou
Vassilios Liakopoulos

Frontiers in Pediatrics

doi 10.3389/fped.2021.702778

4,063 views
3 citations

Original Research

Published on 21 Jan 2022

Cholecalciferol vs. Small Doses of Alfacalcidol vs. Placebo in Chronic Kidney Disease Patients on Hemodialysis: A Randomized Parallel Group Study

in Nephrology

Joanna Matuszkiewicz-Rowińska
Paweł Kulicki
Paweł Zebrowski
Wiesław Klatko
Antoni Sokalski
Stanisław Niemczyk
Magdalena Wypych-Birecka
Jolanta Małyszko

Frontiers in Medicine

doi 10.3389/fmed.2021.781191

15,470 views
9 citations

Original Research

Published on 27 Nov 2025

Effectiveness of treatments to prevent femoral periprosthetic bone loss following total hip arthroplasty: a network meta-analysis

in Pharmacogenetics and Pharmacogenomics

Zhi-Hu Zhao
Tao Ling
Songqing Ye
Wei Luo
Jian-Xiong Ma
Xinlong Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1566890

1,516 views
1 citation

Systematic Review

Published on 19 Apr 2022

Efficacy and Safety of Eldecalcitol for Osteoporosis: A Meta-Analysis of Randomized Controlled Trials

in Bone Research

Hongyan Liu
Guoqi Wang
Ting Wu
Yiming Mu
Weijun Gu

Frontiers in Endocrinology

doi 10.3389/fendo.2022.854439

8,378 views
12 citations

Case Report

Published on 30 Jun 2022

Case Report: Inactivating PTH/PTHrP Signaling Disorder Type 1 Presenting With PTH Resistance

in Pediatric Endocrinology

Tanguy Demaret
René Wintjens
Gwenaelle Sana
Joachim Docquir
Frederic Bertin
Christophe Ide
Olivier Monestier
Deniz Karadurmus
Valerie Benoit
Isabelle Maystadt

Frontiers in Endocrinology

doi 10.3389/fendo.2022.928284

4,741 views
7 citations

Original Research

Published on 06 Jul 2022

Bone Specific Alkaline Phosphatase and Serum Calcification Propensity Are Not Influenced by Etelcalcetide vs. Alfacalcidol Treatment, and Only Bone Specific Alkaline Phosphatase Is Correlated With Fibroblast Growth Factor 23: Sub-Analysis Results of the ETACAR-HD Study

in Nephrology

Katharina Dörr
Sebastian Hödlmoser
Michael Kammer
Roman Reindl-Schwaighofer
Matthias Lorenz
Bianca Reiskopf
Rahel Jagoditsch
Rodrig Marculescu
Rainer Oberbauer

Frontiers in Medicine

doi 10.3389/fmed.2022.948177

3,471 views
5 citations

Articles

Effects of active vitamin D analogues on muscle strength and falls in elderly people: an updated meta-analysis

Association Between Secondary Hyperparathyroidism and Body Composition in Pediatric Patients With Moderate and Advanced Chronic Kidney Disease

Cholecalciferol vs. Small Doses of Alfacalcidol vs. Placebo in Chronic Kidney Disease Patients on Hemodialysis: A Randomized Parallel Group Study

Effectiveness of treatments to prevent femoral periprosthetic bone loss following total hip arthroplasty: a network meta-analysis

Efficacy and Safety of Eldecalcitol for Osteoporosis: A Meta-Analysis of Randomized Controlled Trials

Case Report: Inactivating PTH/PTHrP Signaling Disorder Type 1 Presenting With PTH Resistance

Bone Specific Alkaline Phosphatase and Serum Calcification Propensity Are Not Influenced by Etelcalcetide vs. Alfacalcidol Treatment, and Only Bone Specific Alkaline Phosphatase Is Correlated With Fibroblast Growth Factor 23: Sub-Analysis Results of the ETACAR-HD Study